Synlett 2010(8): 1255-1259  
DOI: 10.1055/s-0029-1219839
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Stereoselective Synthesis of (-)-PF1163A via Prins Cyclization

Jhillu S. Yadav*, M. Venkatesh, N. Thrimurtulu, Attaluri R. Prasad
Organic Division I, Indian Institute of Chemical Technology, Hyderabad 500007, India
Fax: +91(40)27160512; e-Mail: yadavpub@iict.res.in;
Further Information

Publication History

Received 14 December 2009
Publication Date:
16 April 2010 (online)

Abstract

A highly stereoselective and convergent total synthesis of PF1163 A is described while proving the versatility of Prins cyclization in natural product synthesis. The Prins cyclization, Yamaguchi esterification, and ring-closing metathesis reactions are the key steps utilized in the synthesis of macrolactone.

    References

  • 1a Nose H. Seki A. Yaguchi T. Hosoya A. Sasaki T. Hoshoko S. Shomura T. J. Antibiot.  2000,  53:  33 
  • 1b Sasaki T. Nose H. Hosoya A. Yoshida S. Kawaguchi M. Watanabe T. Usui T. Ohtsuka Y. Shomura T. Takano S. Tatsuta K. J. Antibiot.  2000,  53:  38 
  • 2 Tatsuta K. Takano S. Ikeda Y. Nakano S. Miyazaki S. J. Antibiot.  1999,  52:  1146 
  • For the Prins cyclization, see for example:
  • 3a Barry CSJ. Crosby StR. Harding JR. Hughes RA. King CD. Parker GD. Willis CL. Org. Lett.  2003,  5:  2429 
  • 3b Yang X.-F. Mague JT. Li C.-J. J. Org. Chem.  2001,  66:  739 
  • 3c Aubele DL. Wan S. Floreancig PE. Angew. Chem. Int. Ed.  2005,  44:  3485 
  • 3d Barry CS. Bushby N. Harding JR. Willis CS. Org. Lett.  2005,  7:  2683 
  • 3e Cossey KN. Funk RL. J. Am. Chem. Soc.  2004,  126:  12216 
  • 3f Crosby SR. Harding JR. King CD. Parker GD. Willis CL. Org. Lett.  2002,  4:  3407 
  • 3g Marumoto S. Jaber JJ. Vitale JP. Rychnovsky SD. Org. Lett.  2002,  4:  3919 
  • 3h Kozmin SA. Org. Lett.  2001,  3:  755 
  • 3i Jaber JJ. Mitsui K. Rychnovsky SD. J. Org. Chem.  2001,  66:  4679 
  • 3j Kopecky DJ. Rychnovsky SD.
    J. Am. Chem. Soc.  2001,  123:  8420 
  • 3k Rychnovsky SD. Thomas CR. Org. Lett.  2000,  2:  1217 
  • 3l Rychnovsky SD. Yang G. Hu Y. Khire UR. J. Org. Chem.  1997,  62:  3022 
  • 3m Su Q. Panek JS. J. Am. Chem. Soc.  2004,  126:  2425 
  • 3n Yadav JS. Reddy BVS. Sekhar KC. Gunasekar D. Synthesis  2001,  885 
  • 3o Yadav JS. Reddy BVS. Reddy MS. Niranjan N. J. Mol. Catal. A: Chem.  2004,  210:  99 
  • 3p Yadav JS. Reddy BVS. Reddy MS. Niranjan N. Prasad AR. Eur. J. Org. Chem.  2003,  1779 
  • 4a Yadav JS. Reddy MS. Rao PP. Prasad AR. Tetrahedron Lett.  2006,  47:  4397 
  • 4b Yadav JS. Reddy MS. Prasad AR. Tetrahedron Lett.  2006,  47:  4937 
  • 4c Yadav JS. Reddy MS. Prasad AR. Tetrahedron Lett.  2005,  46:  2133 
  • 4d Yadav JS. Reddy MS. Prasad AR. Tetrahedron Lett.  2006,  47:  4995 
  • 4e Yadav JS. Reddy MS. Rao PP. Prasad AR. Synlett  2007,  2049 
  • 4f Yadav JS. Rao PP. Reddy MS. Rao NV. Prasad AR. Tetrahedron Lett.  2007,  48:  1469 
  • 4g Yadav JS. Kumar NN. Reddy MS. Prasad AR. Tetrahedron  2006,  63:  2689 
  • 4h Rao AVR. Reddy ER. Joshi BV. Yadav JS. Tetrahedron Lett.  1987,  28:  6497 
  • 4i Yadav JS. Sridhar Reddy M. Rao PP. Prasad AR. Synlett  2007,  2049 
  • 4j Yadav JS. Hissana A. Gayathri KU. Rao NV. Prasad AR. Synthesis  2008,  3945 
  • 4k Yadav JS. Thrimurtulu N. Uma Gayathri K. Reddy BVS. Prasad AR. Tetrahedron Lett.  2008,  49:  6617 
  • 6 Bouazza F. Renoux B. Bachmann C. Gesson J.-P. Org. Lett.  2003,  5:  4049 
  • 7 Boger DL. Yohannes D. J. Org. Chem.  1988,  53:  487 
  • 8 Inanaga J. Hirata K. Saeki H. Katsuki T. Yamaguchi M. Bull. Chem. Soc. Jpn.  1979,  52:  1989 
  • 9a Sakaitani M. Ohfune Y. J. Org. Chem.  1990,  55:  870 
  • 9b Chandrasekhar S. Yaragorla SR. Sreelakshmi L. Reddy ChR. Tetrahedron  2008,  64:  5174 
  • 9c Chandrasekhar S. Yaragorla SR. Sreelakshmi L. Tetrahedron Lett.  2007,  48:  7339 
  • 10a Scholl M. Ding S. Lee C. Grubbs RH. Org. Lett.  1999,  1:  953 
  • 10b Chatterjee AK. Morgan JP. Scholl M. Grubbs RH. J. Am. Chem. Soc.  2000,  122:  3783 
5

Aldehyde 9 was prepared from (R)-citronellol in two steps in 76% overall yield as shown in Scheme  [4] .

Scheme 4

11

{(2 S ,4 R )-6-[( R )-5-(Benzyloxy)-3-methylpentyl]-tetrahydro-4-(methoxymethoxy)-2 H -pyran-2-yl} Methyl 4-Methylbenzenesulfonate (10)
To a stirred solution of alcohol 9 (1.8 g, 3.78 mmol) in anhyd CH2Cl2 (20 mL) at 0 ˚C were added DIPEA (1.31 mL, 7.56 mmol), DMAP (cat.) and MOMCl (0.91 g, 11.34 mmol) successively, the resulting mixture was stirred for 3 h at r.t. and then quenched by adding H2O (10 mL) and extracted with CH2Cl2 (3 Ž 20 mL). The organic extracts were washed with brine (10 mL), dried over anhyd Na2SO4, and concentrated under reduced pressure to remove the solvent, and the crude residue was purified by column chromatography to afford the pure product 10 as a liquid (1.80 g, 92%). R f  = 0.7 (SiO2, 10% EtOAc in hexane); clear oil; R f  = 0.5 (EtOAc-hexane, 3:7). [α]D ²0 -2.6 (c 1.15, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.82-7.76 (m, 2 H), 7.38-7.22 (m, 7 H), 4.66 (s, 2 H), 4.49 (s, 2 H), 4.14-3.92 (m, 2 H), 3.73-3.61 (m, 1 H), 3.59-3.43 (m, 3 H), 3.35 (s, 3 H), 3.25-3.14 (m, 1 H), 2.43 (s, 3 H), 1.98-1.88 (dd, 2 H, J = 9.4, 2.8 Hz), 1.78-1.01 (m, 10 H), 0.87 (d, 3 H, J = 6.4 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 144.6, 138.6, 132.9, 129.7, 128.3, 127.9, 127.5, 127.4, 94.3, 76.1, 72.8, 72.5, 72.4, 72.0, 68.5, 55.2, 38.0, 36.6, 34.4, 33.1, 32.5, 29.8, 21.5, 19.5. IR (KBr): νmax = 2922, 2852, 1456, 1362, 1037, 979 cm. ESI-MS: m/z= 521 [M+ + H], 543 [M+ + Na].
(4 S ,6 S ,9 R )-4-(Methoxymethoxy)-9-methyldodec-11-en-6-ol (16)
To a stirred soln of 15 (0.8 g, 2.15 mmol) in anhyd THF (8 mL), TBAF (4.3 mL, 4.3 mmol) was added, and the mixture was stirred at 0 ˚C for 2 h. The reaction mixture was quenched with H2O (5 mL) and extracted with EtOAc (2 × 5 mL), and the combined organic layers washed with brine (10 mL), dried over anhyd Na2SO4, and concentrated under reduced pressure to remove the solvent. The crude residue was then purified by column chromatography on silica gel (EtOAc-hexane, 1:9) to afford 16 as a white solid; yield 0.46 g (83%); clear oil; R f  = 0.4 (EtOAc-hexane, 2:8); [α]D ²0 +12.1 (c 0.9, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 5.85-5.70 (m, 1 H), 5.05-4.94 (m, 2 H), 4.76-4.62 (m, 2 H), 3.90-3.76 (m, 2 H), 3.40 (s, 2 H), 2.13-2.02 (m, 1 H), 1.96-1.84 (m, 1 H), 1.68-1.08 (m, 10 H), 0.99-0.84 (m, 6 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.5, 115.5, 96.2, 75.9, 68.2, 55.8, 41.2, 41.1, 37.0, 34.9, 32.9, 32.4, 19.4, 18.7, 14.1. IR (KBr): νmax = 3453, 2930, 1459, 1376, 1038, 911 cm. ESI-MS: m/z= 281 [M+ + Na].
(2 S )-(4 S ,6 S ,9 R )-4-(Methoxymethoxy)-9-methyldodec-11-en-6-yl 3-{4-[2-(benzyloxy)ethoxy]phenyl}-2-( N -Methylbut-3-enamido) Propanoate (19)
To a stirred solution of N-Boc-deprotected amine (200 mg, 0.35 mmol) in anhyd CH2Cl2 (12 mL) was added carboxylic acid fragment B (33 mg, 0.38 mmol) and then HOBt (4 mg, 0.035 mmol) followed by EDCI (201 mg, 1.05 mmol). The reaction was stirred for 6 h at r.t., quenched with HCl (1 N, 15 mL), and diluted with Et2O (20 mL). The aqueous layer was extracted with Et2O (20 mL), and the resulting solution washed with brine (10 mL), dried over Na2SO4, filtered, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (EtOAc-hexane, 3:7) to afford diene 2 as a colorless oil (160 mg, 75%). R f  = 0.4 (EtOAc-hexane, 3:7); [α]D ²0 -9.3 (c 0.5,CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.36-7.23 (m, 5 H), 7.11-7.01 (m, 2 H), 6.86-6.77 (m, 2 H), 5.85-5.65 (m, 2 H), 5.35-5.27 (m, 1 H), 5.11-4.90 (m, 4 H), 4.64-4.44 (m, 4 H), 4.13-4.06 (m, 2 H), 3.82-3.76 (m, 2 H), 3.51-3.39 (m, 1 H), 3.36-3.18 (m, 4 H), 3.14-2.86 (m, 4 H), 2.82 (s, 3 H), 2.10-1.96 (m, 1 H), 1.94-1.80 (m, 1 H), 1.67-1.19 (m, 11 H), 0.95-0.82 (m, 6 H). ¹³C NMR (75 MHz, CDCl3): δ = 171.1, 169.5, 157.6, 137.1, 131.0, 129.8, 129.1, 128.4, 127.7, 117.7, 115.9, 114.9, 114.6, 96.2, 74.5, 73.4, 72.8, 68.5, 67.3, 57.8, 55.8, 41.3, 39.2, 38.9, 37.4, 33.9, 32.7, 32.3, 31.6, 29.8, 19.4, 18.2, 14.3. IR (KBr): νmax = 2924, 2856, 1650, 1243, 1046 cm. ESI-MS: m/z= 660 [M+ + Na].
(3 S ,10 R ,13 S )-3-[4-(2-hydroxyethoxy)benzyl]-13- S -2-(methoxymethoxy)pentyl-4,10-dimethyl-1-oxa-4-azacyclotridecane-2,5-dione (21)
To solution of compound 20 (0.200 g, 0.328 mmol) in EtOAc (10 mL) was added Pd/C 10% (50 mg) and the mixture stirred under H2 atmosphere for 7 h. After completion, the reaction mass was filtered through Celite, and the solvent was removed under reduced pressure to give crude product 21. Purification using column chromatog-raphy on silica gel (hexane-EtOAc, 4:1) gave pure product as a colorless solid (0.145 g, 85% yield); [α]D ²5 -48.5 (c 0.5, CHCl3). ¹H NMR (300 MHz, CDCl3): δ = 7.22-7.07 (m, 2 H), 6.83 (d, 2 H, J = 8.5 Hz), 5.13-5.02 (m, 1 H), 4.66-4.39 (m, 2 H), 4.08-4.02 (m, 2 H), 3.97-3.90 (m, 2 H), 3.35 (s, 3 H), 3.23-3.11 (t, 1 H, J = 11.1 Hz), 3.07-2.91 (m, 3 H), 2.88-2.57 (m, 1 H), 2.26-2.07 (m, 1 H), 1.72-1.08 (m, 19 H), 0.92-0.89 (m, 2 H), 0.85 (t, 3 H, J = 6.8 Hz), 0.81 (d, 3 H, J = 6.2 Hz). ¹³C NMR (75 MHz, CDCl3): δ = 169.9, 130.2, 129.9, 114.8, 114.5, 75.4, 72.2, 69.0, 61.45, 55.7, 55.5, 39.0, 38.7, 37.3, 33.5, 33.3, 31.5, 30.1, 29.6, 25.1, 24.1, 20.5, 17.9, 14.2. IR (film): ν = 3437 (OH), 2926, 2869, 1728, 1636, 1512, 1247, 1038 cm. ESI-MS: m/z = 544 [M + Na]+.
(3 S ,10 R ,13 S )-3-[4-(2-hydroxyethoxy)benzyl]-13-[( S )-2-hydroxy pentyl]-4,10-dimethyl-1-oxa-4-azacyclotridecane-2,5-dione [PF1163 A(1)] To a stirred solution of 21 (0.02 g, 0.03 mmol) in anhyd TFA-CH2Cl2 (1:5, 2 mL) was added at 0 ˚C, and the reaction mixture was stirred for 2 h at r.t. The reaction mixture was quenched with NaHCO3 (1 mL) and extracted with CH2Cl2 (2 × 2 mL), and the combined organic layers were washed with brine (2 mL), dried (Na2SO4), and concentrated under reduced pressure. The residue was purified by silica gel chromatography (EtOAc-hexane, 3:7) to afford 1 as a colorless oil (13 mg, 75%). R f  = 0.4 (EtOAc-hexane, 7:3); [α]D ²0 -88.5 (c 1.0, MeOH). ¹H NMR (200 MHz, CDCl3):
δ = 7.20-7.03 (m, 2 H), 6.84-6.75 (m, 2 H), 5.82-5.66 (m, 1 H), 5.14-4.91 (m, 1 H), 4.01 (s, 1 H), 3.90 (s, 1 H), 3.53-3.27 (m, 2 H), 3.01-2.80 (m, 3 H), 2.78-2.52 (m, 1 H), 2.38-2.24 (m, 1 H), 1.76-1.02 (m, 22 H), 0.91 (t, J = 7.8 Hz, 3 H), 0.82 (d, J = 7.8 Hz, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 173.9, 171.7, 157.4, 130.3, 128.8, 114.5, 73.2, 69.1, 66.6, 61.3, 56.0, 49.4, 42.1, 39.0, 33.9, 33.2, 29.7, 24.1, 20.7, 19.0, 14.0. IR (KBr): νmax = 3429, 2924, 2856, 1728, 1632, 1511, 1459, 1247 cm. ESI-HRMS: m/z [M + Na]+ calcd for C27H43O6NNa: 500.2988; found: 500.2979.